Tata Capital IPO 2025

AB TADKA
0
Tata Capital IPO (2025): GMP, Price Band, Dates, Lot Size, Subscription, Allotment, Listing — Full Guide (Hindi + English)

Tata Capital IPO (2025): GMP, Price Band, Dates, Lot Size, Subscription, Allotment, Listing — Full Guide (Hindi + English)


Quick Snapshot

  • Issue size: ₹15,511.87 crore (Fresh ₹6,846 cr + OFS ₹8,665.87 cr). [web:17][web:18][web:20]
  • Price band: ₹310–₹326 per share (cap price ₹326). [web:15][web:17][web:22]
  • Lot size: 46 shares (min invest ≈ ₹14,996 at cap). [web:17][web:22][web:24]
  • Dates: Oct 6–8, 2025; Allotment Oct 9; Listing Oct 13 (tentative). [web:17][web:23][web:26]
  • GMP latest: about ₹7.5–₹12.5 today; implied listing near ₹333–₹339. [web:12][web:15][web:25]
  • Anchor: 14.2387 crore shares allotted at ₹326 to anchors (as per live tracker). [web:19]
  • Subs status early: Day 1 partial subscription with QIB lead; live blogs show 14–39% by midday snapshots. 

What is the Tata Capital IPO?

Tata Capital Limited, the flagship financial services arm of the Tata Group and a subsidiary of Tata Sons, is launching a mainboard IPO to raise about ₹15,511.87 crore via a mix of a fresh issue and an OFS, primarily to bolster Tier-I capital and fund growth across retail and SME lending products. [web:17][web:18][web:20]

The IPO is open from Oct 6 to Oct 8, 2025, with a price band of ₹310–₹326 per share and a retail lot size of 46 shares, listing on BSE and NSE, with allotment likely on Oct 9 and listing on Oct 13, subject to confirmations. 

टाटा कैपिटल IPO क्या है? (Hindi)

टाटा ग्रुप की वित्तीय सेवा कंपनी टाटा कैपिटल लिमिटेड लगभग ₹15,511.87 करोड़ का मेनबोर्ड IPO ला रही है, जिसमें फ्रेश इश्यू और OFS शामिल है, जिसका प्रमुख उद्देश्य Tier‑I कैपिटल मजबूत करना और रिटेल/SME लेंडिंग वृद्धि को फंड करना है। [web:17][web:18][web:20]

यह इश्यू 6–8 अक्टूबर 2025 तक खुला है, प्राइस बैंड ₹310–₹326, लॉट साइज 46 शेयर है, BSE/NSE पर लिस्टिंग प्रस्तावित है, अलॉटमेंट 9 अक्टूबर और लिस्टिंग 13 अक्टूबर को संभावित है। [web:17][web:24][web:23]


Key IPO Terms and Timeline

  • Price band: ₹310–₹326 per share; face value ₹10. [web:22][web:17]
  • Lot size: 46 shares; minimum invest about ₹14,996 at the cap. [web:22][web:24]
  • Fresh issue: ~21 crore shares; OFS: ~26.58 crore shares (Tata Sons + IFC). [web:17][web:20]
  • Issue opens: Oct 6; closes: Oct 8; allotment: Oct 9; listing: Oct 13 (tentative). [web:17][web:23][web:26]
  • Use of proceeds: Augment Tier-I capital; onward lending and business growth. [web:17][web:18]

GMP Today and Expected Listing Price

Investorgain’s live GMP shows approximately ₹12.5 at day-end snapshots, while Moneycontrol tracking cites around ₹7.5–₹10 in live updates; extrapolating on cap price ₹326 implies an estimated listing price of ₹333–₹339, i.e., a modest 2–4% premium, but GMPs can swing intraday. [web:12][web:15][web:25]

GMP is an unofficial indicator and not a guarantee; investors should consider fundamentals, peer multiples, and risk appetite before applying. [web:25]


Business Overview and Strengths

  • Scope: 25+ lending products servicing salaried, self-employed, SMEs, and corporates; also distributes insurance/credit cards, wealth management, and PE fund roles. [web:17]
  • Regulatory: Classified as Upper Layer NBFC by RBI with a strong systems framework. [web:17]
  • Scale: 7.3 million customers served cumulatively as of June 30, 2025, showcasing deep market penetration. [web:17]
  • Brand and parentage: Backed by Tata Group’s governance and access advantages, aiding liability management. [web:17][web:20]

Issue Structure and Promoter Selling

The IPO comprises a fresh issue of ~21.0 crore shares (~₹6,846 crore) and an OFS of ~26.5824 crore shares (~₹8,665.87 crore) by Tata Sons and IFC, leading to around 11% dilution, aiming to balance growth funding with shareholder liquidity. [web:17][web:20]

Anchor allocation note indicates ~14.24 crore shares allotted at ₹326 to anchor investors, adding demand visibility pre-opening day. [web:19]


Valuation, Peers and Street View

Street commentary suggests the IPO is priced near 4x FY25 P/B at the upper band, broadly in line with quality NBFC peers, with a P/E in the mid-30s on near-term earnings, reflecting brand premium and growth expectations. [web:15]

Brokerage notes highlight asset quality, diversified book, and “phygital” model as positives, while cautioning that valuations already embed a quality premium versus sector averages. [web:15]


मूल्यांकन, पीयर और स्ट्रीट व्यू (Hindi)

ऊपरी बैंड पर FY25 P/B ~4x और P/E ~34x के आसपास आंका जा रहा है, जो क्वालिटी NBFC पीयर के अनुरूप है और टाटा ब्रांड प्रीमियम को परिलक्षित करता है। [web:15]

ब्रोकरेज आकलन के अनुसार एसेट क्वालिटी, विविधित पोर्टफोलियो और ‘फिजिटल’ मॉडल सकारात्मक हैं, हालांकि सेक्टर औसत की तुलना में वैल्युएशन प्रीमियम पहले से मौजूद है। [web:15]


Important Dates and How to Apply (Step-by-Step)

  • Open: Oct 6, 2025 • Close: Oct 8, 2025 • Allotment: Oct 9 • Refunds: Oct 10 • Listing: Oct 13 (tentative). [web:17][web:23][web:26]
  • UPI/ASBA Apply: Through broker apps (Zerodha, Groww) or bank net-banking; confirm UPI mandate before cut-off. [web:26][web:21]


Step-by-Step (English)

  1. Check price band ₹310–₹326 and decide lot multiples (46 shares per lot). [web:22][web:24]
  2. Open your broker/bank IPO section; select Tata Capital IPO. [web:26][web:21]
  3. Enter lots, confirm bid at cut-off price if unsure; submit with UPI/ASBA. [web:26][web:21]
  4. Approve UPI mandate promptly; ensure funds are blocked. [web:26][web:21]
  5. Track subscription; allocation likely Oct 9; refunds Oct 10; listing Oct 13. [web:23][web:26]

स्टेप-बाय-स्टेप (Hindi)

  1. प्राइस बैंड ₹310–₹326 देखें और 46 शेयर प्रति लॉट के हिसाब से मात्रा तय करें। [web:22][web:24]
  2. ब्रोकर/बैंक ऐप में IPO सेक्शन खोलें और Tata Capital IPO चुनें। [web:26][web:21]
  3. लॉट दर्ज कर कट-ऑफ प्राइस सिलेक्ट करें; UPI/ASBA से सबमिट करें। [web:26][web:21]
  4. UPI मैंडेट तुरन्त अप्रूव करें ताकि फंड ब्लॉक हो जाएँ। [web:26][web:21]
  5. सब्सक्रिप्शन देखें; अलॉटमेंट 9 अक्टूबर, रिफंड 10 अक्टूबर, लिस्टिंग 13 अक्टूबर सम्भावित। [web:23][web:26]

Live Subscription and Market Mood

Day 1 snapshots show early QIB-led traction with reports ranging from ~14% to ~39% subscribed during the opening hours; live numbers fluctuate through the day and across exchanges. [web:18][web:15][web:23]

This is one of 2025’s larger issues, and mainstream financial portals are providing rolling updates on segment-wise bids and GMP ticks. [web:20][web:29]


Key Risks

  • Macro and rate-cycle sensitivity: NBFC profitability is rate and liquidity dependent; higher rates can compress NIMs. [web:15]
  • Valuation premium: Quality premium may cap listing gains if market mood weakens; GMP already indicates modest upside. [web:15][web:12]
  • Competition: Strong peers in retail/SME lending and fintechs intensify acquisition costs and credit risk calibration. [web:15]
  • Regulatory: RBI’s upper-layer oversight can tighten norms, impacting growth capital needs and buffers. [web:17]

Who Should Consider Applying?

Long-term investors seeking exposure to a large, diversified NBFC with strong parentage and a scalable retail/SME franchise may consider a “Subscribe” stance, given stable asset quality, digital push, and capital augmentation plan. [web:15][web:17]

Short-term listing gains seekers should temper expectations since current GMP suggests low-single digit premium; outcomes can vary with broader market risk-on/risk-off shifts. [web:12][web:15]


How Many Lots Should Retail Consider?

Given the modest GMP and meaningful overall issue size, a calibrated approach—1 to 3 lots depending on individual risk tolerance and capital availability—could balance allocation odds versus exposure risk, while avoiding over-leverage near listing. [web:12][web:15]


Pre-Apply Checklist

  • UPI limit and bank mandate approvals working today. [web:26]
  • Sufficient funds for chosen lots at cap price. [web:22][web:24]
  • Broker app updated; exchange downtime windows noted. [web:26]
  • Review RHP and brokerage notes for the latest financials and covenants. [web:17][web:15]

Important References

  • Investorgain GMP page and live GMP coverage for Tata Capital IPO. [web:12][web:25]
  • Investorgain IPO details page and subscription tracker. [web:13][web:19]
  • Kotak Securities IPO details, use of proceeds, lot size, dates. [web:17]
  • Moneycontrol live blog on GMP and subscription updates. [web:15]
  • Chittorgarh IPO summary: band, lot, dates. [web:22]
  • Zerodha/Groww IPO pages for retail flow and timelines. [web:26][web:21]
  • TOI/ET live updates for macro coverage and context. [web:20][web:29]

FAQs (English + Hindi)

1) What are the Tata Capital IPO dates?

Open Oct 6, Close Oct 8; allotment Oct 9; listing Oct 13 (tentative). [web:17][web:23][web:26]

1) टाटा कैपिटल IPO की तिथियाँ क्या हैं? (Hindi)

ओपन 6 अक्टूबर, क्लोज 8 अक्टूबर; अलॉटमेंट 9 अक्टूबर; लिस्टिंग 13 अक्टूबर (संभावित)। [web:17][web:23][web:26]

2) What is the price band and lot size?

Band ₹310–₹326; lot size 46 shares; minimum approx ₹14,996 at the cap. [web:22][web:24]

2) प्राइस बैंड और लॉट साइज क्या है? (Hindi)

प्राइस बैंड ₹310–₹326; लॉट साइज 46 शेयर; न्यूनतम निवेश लगभग ₹14,996 (कैप). [web:22][web:24]

3) What is today’s GMP and expected listing?

GMP around ₹7.5–₹12.5 today; implied listing ~₹333–₹339 if sustained, but volatile. [web:12][web:15][web:25]

3) आज का GMP और अपेक्षित लिस्टिंग क्या है? (Hindi)

GMP लगभग ₹7.5–₹12.5; अनुमानित लिस्टिंग ~₹333–₹339, पर यह बदल सकता है। [web:12][web:15][web:25]

4) How to check allotment?

Use registrar/exchange link on or after Oct 9; Investorgain allotment page lists status and links. [web:16]

4) अलॉटमेंट कैसे देखें? (Hindi)

9 अक्टूबर से रजिस्ट्रार/एक्सचेंज लिंक पर; Investorgain अलॉटमेंट पेज पर स्टेटस लिंक मिलेंगे। [web:16]

5) Should long-term investors apply?

Brokerage notes skew positive on brand, asset quality, and capital plan; valuation at a premium—suitable for quality-focused, long-horizon portfolios. [web:15]

5) दीर्घकालिक निवेशक अप्लाई करें? (Hindi)

ब्रोकरेज व्यू सकारात्मक; पर वैल्युएशन प्रीमियम है—गुणवत्ता-उन्मुख, लंबी अवधि के निवेशकों के अनुकूल। [web:15]


Final Take

Tata Capital combines scale, brand trust, and diversified lending with capital augmentation, but near-term listing gains may be modest per live GMP—position size prudently, focus on fundamentals, and monitor subscription momentum into Day 3. [web:17][web:12][web:15]

Pro tip: Approve the UPI mandate quickly and ensure funds are intact until allotment to avoid bid rejection, then track the allotment link on Oct 9. [web:26][web:16]

Post a Comment

0 Comments

Post a Comment (0)
10/related/default